We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRT
1726
North European Oil Royalty Trust
NRT
$84.4M
– –
-9,465
Closed -$207K
NTGR icon
1727
NETGEAR
NTGR
$641M
– –
-6,939
Closed -$214K
NWL icon
1728
Newell Brands
NWL
$2.7B
– –
-12,815
Closed -$352K
OC icon
1729
Owens Corning
OC
$11.5B
– –
-35,909
Closed -$1.36M
OFS icon
1730
OFS Capital
OFS
$45.8M
– –
-14,100
Closed -$179K
OI icon
1731
O-I Glass
OI
$1.13B
– –
-7,413
Closed -$223K
OLN icon
1732
Olin
OLN
$2.1B
– –
-34,938
Closed -$806K
OPCH icon
1733
Option Care Health
OPCH
$3.58B
– –
-6,055
Closed -$213K
ORCL icon
1734
Oracle
ORCL
$403B
– –
-43,614
Closed -$1.45M
PANW icon
1735
Palo Alto Networks
PANW
$280B
– –
-28,422
Closed -$217K
PARA
1736
DELISTED
Paramount Global Class B
PARA
– –
-76,585
Closed -$4.22M
PATK icon
1737
Patrick Industries
PATK
$2.77B
– –
-40,122
Closed -$357K
PBF icon
1738
PBF Energy
PBF
$8.28B
– –
-53,566
Closed -$1.2M
PBR icon
1739
Petrobras
PBR
$123B
– –
-11,155
Closed -$173K
PBYI icon
1740
Puma Biotechnology
PBYI
$387M
– –
-11,500
Closed -$617K
PCAR icon
1741
PACCAR
PCAR
$69.7B
– –
-58,491
Closed -$2.17M
PEO
1742
Adams Natural Resources Fund
PEO
$737M
– –
-8,819
Closed -$230K
PFBC icon
1743
Preferred Bank
PFBC
$1.26B
– –
-12,379
Closed -$220K
PH icon
1744
Parker-Hannifin
PH
$124B
– –
-5,150
Closed -$560K
PIPR icon
1745
Piper Sandler
PIPR
$5.09B
– –
-30,800
Closed -$264K
PM icon
1746
Philip Morris
PM
$295B
– –
-3,500
Closed -$303K
PLXS icon
1747
Plexus
PLXS
$6.88B
– –
-5,544
Closed -$206K
POST icon
1748
Post Holdings
POST
$4.11B
– –
-10,566
Closed -$279K
PRGS icon
1749
Progress Software
PRGS
$1.71B
– –
-17,409
Closed -$451K
PROV icon
1750
Provident Financial
PROV
$112M
– –
-16,790
Closed -$279K
68 69
70
71 72

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.